These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29916999)

  • 1. Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis.
    Portela RC; Fares NT; Machado LF; São Leão AF; de Freitas D; Paranhos A; Prata TS; Gracitelli CPB
    J Glaucoma; 2018 Sep; 27(9):794-801. PubMed ID: 29916999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Ocular Surface Disease in Glaucoma: A Comparative Analysis of Symptoms and Objective Parameters.
    Romano J; Ferreira N; Godinho G; Tomás R; Oliveira N; Sousa JP
    Cureus; 2024 Feb; 16(2):e54070. PubMed ID: 38481920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops.
    Pérez Bartolomé F; Martínez de la Casa JM; Arriola Villalobos P; Fernández Pérez C; Polo V; Sánchez Jean R; García Feijoó J
    Semin Ophthalmol; 2018; 33(5):643-650. PubMed ID: 29144869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.
    Saade CE; Lari HB; Berezina TL; Fechtner RD; Khouri AS
    Can J Ophthalmol; 2015 Apr; 50(2):132-6. PubMed ID: 25863853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis.
    Fares NT; Portela RC; Machado LF; Polizelli M; Freitas D; Paranhos A; Prata TS; Gracitelli CPB
    Arq Bras Oftalmol; 2021; 84(4):345-351. PubMed ID: 33567039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.
    Guarnieri A; Carnero E; Bleau AM; Alfonso-Bartolozzi B; Moreno-Montañés J
    Int Ophthalmol; 2020 Mar; 40(3):741-751. PubMed ID: 31813109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma.
    Pérez-Bartolomé F; Martínez-de-la-Casa JM; Arriola-Villalobos P; Fernández-Pérez C; Polo V; García-Feijoó J
    Eur J Ophthalmol; 2017 Nov; 27(6):694-704. PubMed ID: 28497458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of objective ocular redness measured with Keratograph 5M in glaucoma patients after instilling brimonidine drops.
    Montolío-Marzo E; Fernández-Narros R; Morales-Fernández L; García-Bella J; Sáenz-Francés F; García-Feijoo J; Martínez-de-la-Casa JM
    Eur J Ophthalmol; 2024 Mar; 34(2):480-486. PubMed ID: 37661653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular surface disease and glaucoma: how to evaluate impact on quality of life.
    Rossi GC; Pasinetti GM; Scudeller L; Bianchi PE
    J Ocul Pharmacol Ther; 2013 May; 29(4):390-4. PubMed ID: 23215770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors to develop ocular surface disease 
in treated glaucoma or ocular hypertension patients.
    Rossi GC; Pasinetti GM; Scudeller L; Raimondi M; Lanteri S; Bianchi PE
    Eur J Ophthalmol; 2013; 23(3):296-302. PubMed ID: 23335308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy].
    Gomes B; Turiel PR; Marques FP; Bernardo FP; Safady MV; Portes AL; Santhiago MR
    Arq Bras Oftalmol; 2013 Oct; 76(5):282-7. PubMed ID: 24232941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry eye syndrome-related quality of life in glaucoma patients.
    Rossi GC; Tinelli C; Pasinetti GM; Milano G; Bianchi PE
    Eur J Ophthalmol; 2009; 19(4):572-9. PubMed ID: 19551671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular light scatter in patients on topical intraocular pressure-lowering medication.
    Pérez-Bartolomé F; Martínez de la Casa JM; Arriola-Villalobos P; Fernández-Pérez C; García-Feijoó J
    Eur J Ophthalmol; 2018 Nov; 28(6):652-661. PubMed ID: 29631441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular surface disease exacerbated glaucoma: optimizing the ocular surface improves intraocular pressure control.
    Batra R; Tailor R; Mohamed S
    J Glaucoma; 2014 Jan; 23(1):56-60. PubMed ID: 22828007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of glaucoma medications and ocular surface disease on the quality of life of glaucoma patients in the district of Sousse (Tunisia)].
    Leila K; Gatfaoui F; Mahjoub A; Yakoubi S; Krifa F; Ghorbel M; Mahjoub H
    J Fr Ophtalmol; 2019 May; 42(5):464-470. PubMed ID: 30928241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications.
    Uzunosmanoglu E; Mocan MC; Kocabeyoglu S; Karakaya J; Irkec M
    Cornea; 2016 Aug; 35(8):1112-6. PubMed ID: 27055218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meibomian Gland Changes in Open-angle Glaucoma Users Treated with Topical Medication.
    Soriano D; Ferrandez B; Mateo A; Polo V; Garcia-Martin E
    Optom Vis Sci; 2021 Oct; 98(10):1177-1182. PubMed ID: 34678837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
    Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
    Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy.
    Fuente-García C; Muñoz-Negrete FJ; de Dompablo E; Moreno-Montañés J; Rebolleda G
    Indian J Ophthalmol; 2022 May; 70(5):1626-1633. PubMed ID: 35502039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.